LLY Lilly(Eli) & Company

  1. Stocks
  2. Healthcare
  3. NYSE: LLY

Price (delayed)

$1,436.63

Market cap

$1.35T

P/E Ratio

46.57

Dividend/share

$6.69

EPS

$30.85

Enterprise value

$1.4T

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 98

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of ...

Highlights
The equity has surged by 69% year-on-year and by 19% since the previous quarter
The EPS has soared by 51% YoY and by 3.4% QoQ
The P/E is 26% below the 5-year quarterly average of 62.7 but 19% above the last 4 quarters average of 39.3
Lilly(Eli)'s debt has increased by 16% YoY but it has decreased by 10% from the previous quarter
The quick ratio has declined by 12% year-on-year and by 6% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.lilly.com
Peers: BMY MRK JNJ PFE

Key stats

What are the main financial stats of LLY

LLY stock price

How has the Lilly(Eli) stock price performed over time
Intraday
-0.05%
1 week
5.27%
1 month
21.48%
1 year
41.15%
YTD
33.68%
QTD
24.16%

Financial performance

How have Lilly(Eli)'s revenue and profit performed over time
Revenue
$86.46B
Gross profit
$72.31B
Operating income
$35.34B
Net income
$27.58B
Gross margin
83.6%
Net margin
31.9%
LLY's operating income has surged by 52% year-on-year and by 3.6% since the previous quarter
The net income has grown by 50% YoY and by 3.2% from the previous quarter
The company's gross profit rose by 47% YoY and by 9% QoQ
Lilly(Eli)'s revenue has increased by 46% YoY and by 9% from the previous quarter

Price vs fundamentals

How does LLY's price correlate with its fundamentals

Growth

What is Lilly(Eli)'s growth rate over time

Valuation

What is Lilly(Eli) stock price valuation
LLY P/E details
P/E
46.57
P/B
33.58
P/S
14.82
EV/EBIT
40.15
EV/EBITDA
37.79
EV/Sales
16.15
The EPS has soared by 51% YoY and by 3.4% QoQ
The P/E is 26% below the 5-year quarterly average of 62.7 but 19% above the last 4 quarters average of 39.3
The equity has surged by 69% year-on-year and by 19% since the previous quarter
LLY's P/B is 16% below its 5-year quarterly average of 40.1 but 6% above its last 4 quarters average of 31.6
Lilly(Eli)'s revenue has increased by 46% YoY and by 9% from the previous quarter
The stock's price to sales (P/S) is 15% more than its last 4 quarters average of 12.9 and 9% more than its 5-year quarterly average of 13.6

Efficiency

How efficient is Lilly(Eli) business performance
The ROIC has grown by 18% YoY
The company's return on equity fell by 18% YoY and by 10% QoQ
The ROA has grown by 10% YoY but it has contracted by 3.6% from the previous quarter
The ROS has increased by 6% YoY but it has decreased by 4.7% QoQ

Dividends

What is LLY's dividend history
Dividend details
DPS
$6.69
Dividend yield
0.47%
Payout ratio
21.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lilly(Eli) financials performed over time
LLY's total assets is 37% greater than its total liabilities
LLY's total assets is up by 29% year-on-year and by 4.1% since the previous quarter
Lilly(Eli)'s total liabilities has increased by 18% YoY
Lilly(Eli)'s debt is 23% more than its equity
The equity has surged by 69% year-on-year and by 19% since the previous quarter
The company's debt to equity fell by 31% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.